Le Lézard
Classified in: Health, Covid-19 virus
Subject: MRR

USD 13.09 bn growth in Molecular Biology Enzymes, Kits, and Reagents Market | Evolving Opportunities with Agilent Technologies Inc. & F. Hoffmann-La Roche Ltd. | 17000 + Technavio Reports


NEW YORK, Nov. 29, 2021 /PRNewswire/ -- The "Molecular Biology Enzymes, Kits, and Reagents Market - Competitive Analysis, Drivers, Challenges & Five Force Analysis" report has been added to Technavio's offering. The molecular biology enzymes, kits, and reagents market value is set to grow by USD 13.09 billion, progressing at a CAGR of 14.61% from 2020 to 2025.

For more insights on the Molecular Biology Enzymes, Kits, and Reagents Market -Download a free sample now!

39% of the market's growth will originate from North America. The US is a key market for molecular biology enzymes, kits, and reagents in the region. The rising incidence of infectious diseases and genetic disorders will facilitate the molecular biology enzymes, kits, and reagents market growth in North America. The report offers an up-to-date analysis of the geographical composition of the market, competitive intelligence, and regional opportunities in store for vendors.

Market Dynamics

Factors such as increased use of proteins and reagents in biotechnology and pharmaceutical companies and the rising number of genome projects will drive the growth of the Molecular Biology Enzymes, Kits, And Reagents Market. However, privacy issues concerning data leakage of genetic information might hamper market growth. The holistic analysis of the drivers will help in predicting end goals and refining marketing strategies to gain a competitive edge.

Company Profiles

The molecular biology enzymes, kits, and reagents market are fragmented and the vendors are deploying various organic and inorganic growth strategies to compete in the market. The molecular biology enzymes, kits, and reagents market report provide complete insights on key vendors including Agilent Technologies Inc., F. Hoffmann-La Roche Ltd., Illumina Inc., Merck KGaA, New England Biolabs Inc., Promega Corp., QIAGEN NV, Rockland Immunochemicals Inc., Takara Bio Inc., and Thermo Fisher Scientific Inc.

Few Companies with Key Offerings

Competitive Analysis

The report includes the competitive analysis, a proprietary tool to analyze and evaluate the position of companies based on their industry position score and market performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Market Segmentation

Related Reports -
Metabolomics Market -The metabolomics market share should rise by USD 1.99 billion from 2021 to 2025 at a CAGR of 11.84%.Download a free sample now!

Immunoprotein Diagnostic Testing Market  - The immunoprotein diagnostic testing market has the potential to grow by USD 11.48 billion during 2021-2025, and the market's growth momentum will accelerate at a CAGR of 8.64%. Download a free sample now!

Molecular Biology Enzymes, Kits, And Reagents Market Scope

Report Coverage

Details

Page number

120

Base year

2020

Forecast period

2021-2025

Growth momentum & CAGR

Accelerate at a CAGR of 14.61%

Market growth 2021-2025

USD 13.09 billion

Market structure

Fragmented

YoY growth (%)

14.30

Regional analysis

North America, Europe, Asia, and ROW

Performing market contribution

North America at 39%

Key consumer countries

US, Germany, UK, China, and Japan

Competitive landscape

Leading companies, competitive strategies, consumer engagement scope

Companies profiled

Agilent Technologies Inc., F. Hoffmann-La Roche Ltd., Illumina Inc., Merck KGaA, New England Biolabs Inc., Promega Corp., QIAGEN NV, Rockland Immunochemicals Inc.  , Takara Bio Inc., and Thermo Fisher Scientific Inc.

Market Dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, market condition analysis for the forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

 

SOURCE Technavio


These press releases may also interest you

at 05:47
Researchers at Noster Inc. report in Medical Mass Spectrometry a method for the efficient quantification of a set of biomolecules produced by gut bacteria breaking down nutrients. The method has important potential for monitoring the composition of...

at 05:45
The "Global Sterilization Equipment Market by Product & Service (Instruments (Dry Heat, Ethylene Oxide), Consumables & Accessories (Indicators, Pouches), Services (Ethylene Oxide, Steam)), End-user (Hospitals & Clinics, Pharmaceuticals), and Region -...

at 05:35
The "miRNA Sequencing and Assay Market Size, Share & Trends Analysis Report by Product & Service, by Technology, by Workflow, by Application, by End-use, by Region, and Segment Forecasts, 2022-2030" report has been added to ResearchAndMarkets.com's...

at 05:20
Bio-Thera Solutions, a commercial-stage biopharmaceutical company developing a pipeline of innovative therapies and a pipeline of biosimilars, today announced the company will present two posters at the 2022 San Antonio Breast Cancer Symposium...

at 05:20
Bio-Thera Solutions, a commercial-stage biopharmaceutical company developing a pipeline of innovative therapies and a pipeline of biosimilars, today announced that Jin-Chen Yu, SVP, Research will present a talk on BAT8009 (B7-H3-ADC) at the 2nd...

at 04:51
Focus-X Therapeutics (referred to here as "Focus-X"), a nuclide drug company that was invested in and incubated by Viva Biotech, successfully reached an acquisition agreement with Full-Life Technologies Co., Ltd. (referred to here as "Full-Life")....



News published on 29 november 2021 at 22:15 and distributed by: